Sanofi India receives order for ₹2.86 Crore tax demand and penalty

Sanofi India Limited has received an order from the Principal/Joint Commissioner of CGST & Central Excise, Mumbai. The order pertains to the period FY 2018-19 till FY 2022-23 and determines a tax dema...

Sanofi India Limited has received an order from the Principal/Joint Commissioner of CGST & Central Excise, Mumbai. The order pertains to the period FY 2018-19 till FY 2022-23 and determines a tax demand of ₹1,43,49,690, a penalty of ₹1,43,49,690, and applicable interest under the CGST and IGST Act, 2017. The alleged contravention relates to the wrong availment and utilization of Input Tax Credit (ITC). The order was dated 29th December 2025 and received by the company on the same date. The company plans to appeal this order before the Higher Tax Authorities. The total quantifiable impact in monetary terms amounts to ₹2,86,99,380 (tax demand and penalty combined), excluding applicable interest.

Limitations of AI summaries

AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.

Platforms like Prysm provide stock-level and portfolio-level analysis.

Why is Sanofi India Limited in the news today?

Sanofi India Limited (SANOFI) is in the news due to the company has received an order for a significant tax demand and penalty, which is a negative development.

Other Regulatory FilingsTaxation
Sanofi India LimitedSANOFIhttps://prysm.fi/v2/analyze/SANOFI

AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

Sanofi India receives order for ₹2.86 Crore tax demand and penalty

December 30, 2025, 10:47 AM

AI Sentiment Analysis

Top Queries to Ask About Sanofi India Limited

More Details on This News

Sanofi India Limited has received an order from the Principal/Joint Commissioner of CGST & Central Excise, Mumbai. The order pertains to the period FY 2018-19 till FY 2022-23 and determines a tax demand of ₹1,43,49,690, a penalty of ₹1,43,49,690, and applicable interest under the CGST and IGST Act, 2017.

The alleged contravention relates to the wrong availment and utilization of Input Tax Credit (ITC). The order was dated 29th December 2025 and received by the company on the same date.

The company plans to appeal this order before the Higher Tax Authorities. The total quantifiable impact in monetary terms amounts to ₹2,86,99,380 (tax demand and penalty combined), excluding applicable interest.

See What Deep Dive Gives You — in Seconds

“what happens when you click Deep Dive “

Instant AI Summary - “Get clean, noise-free earnings breakdowns.”

PDF Insights - “Download detailed, AI-generated reports.”

Metrics Explained -“Key ratios & trends explained in simple language.”

Want to know if this news pushes your stock up or down?

Just tap

deep dive

More News on Sanofi India Limited

Discover more trending news on Prysm

View All